Internal Medicine, Nephrology · Plano, TX
NPI
1841278330
Since 2006
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
4701 Old Shepard Pl Ste 100
Plano, TX, 75093
Phone (214) 358-2300
Groups this clinician bills Medicare through
Medicare paid, 2024
$126K
4,544 services
Medicare patients, 2024
444
Average age 75
Drug cost, 2024
$915K
1,667 prescriptions
Company payments, 2025
$771
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Lori S Glowacki was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 549 times for 290 patients. In total Lori S Glowacki billed 4,544 services in 24 codes, and Medicare paid $126K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-01-10.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 549 | 290 | $11.75 | $6,449 |
| 99214 Office E&M - Established | Office | 358 | 260 | $68.12 | $24K |
| 99215 Office E&M - Established | Office | 169 | 135 | $83.07 | $14K |
| 90960 ESRD Related Services (not dialysis) | Office | 135 | 28 | $251.85 | $34K |
| 99233 Hospital E&M - Subsequent | Facility | 99 | 62 | $88.38 | $8,749 |
| 99232 Hospital E&M - Subsequent | Facility | 93 | 62 | $59.69 | $5,551 |
| 85018 Blood Count | Office | 89 | 15 | $2.32 | $206 |
| 90961 ESRD Related Services (not dialysis) | Office | 79 | 26 | $215.75 | $17K |
| 96372 Injection Administration | Office | 47 | 12 | $10.10 | $475 |
| 99204 Office E&M - New | Office | 42 | 42 | $106.28 | $4,464 |
| 90945 Peritoneal Dialysis | Facility | 12 | 11 | $60.96 | $732 |
By year: 2022 $148K for 14,393 services; 2023 $139K for 7,126 services; 2024 $126K for 4,544 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85018 Blood Count | 89 | 15 | $2.32 | $206 |
Medicare prescription drug claims, 2024
In 2024, the drug Lori S Glowacki prescribed most often to Medicare patients was Farxiga (Dapagliflozin Propanediol), with 291 prescriptions and refills. In total Lori S Glowacki wrote 1,667 Medicare prescriptions that cost $915K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Farxiga Dapagliflozin Propanediol | 291 | 486 | 71 | $273K |
| Doxazosin Mesylate Generic | 104 | 250 | 33 | $2,343 |
| Furosemide Generic | 103 | 274 | 37 | $655 |
| Amlodipine Besylate Generic | 85 | 231 | 28 | $619 |
| Lisinopril Generic | 85 | 193 | 30 | $763 |
| Jardiance Empagliflozin | 78 | 128 | 21 | $73K |
| Sevelamer Carbonate Generic | 77 | 109 | 19 | $14K |
| Allopurinol Generic | 74 | 189 | 25 | $951 |
| Olmesartan Medoxomil Generic | 57 | 129 | 23 | $726 |
| Losartan Potassium Generic | 51 | 141 | 18 | $549 |
| Velphoro Sucroferric Oxyhydroxide | 34 | 46 | Under 11 | $127K |
| Potassium Chloride Generic | 27 | 55 | Under 11 | $1,378 |
| Hydralazine Hcl Generic | 26 | 56 | 11 | $210 |
| Gabapentin Generic | 25 | 41 | Under 11 | $236 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 24 | 32 | 17 | $377 |
Brand drugs: 512 claims; generic drugs: 1,155 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Lori S Glowacki $771 ($771 in general payments such as food, travel and fees) from 12 companies. The largest payer was Amgen Inc. with $159.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 11 | $159 |
| AstraZeneca Pharmaceuticals LP AZN | 6 | $109 |
| Novo Nordisk Inc NVO | 4 | $92.64 |
| Ardelyx, Inc. ARDX | 3 | $86.46 |
| Fresenius USA Marketing, Inc. | 3 | $67.91 |
| Calliditas Therapeutics US Inc. | 2 | $56.65 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 2 | $52.32 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $50.3 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 2 | $35.21 |
| Scpharmaceuticals Inc. SCPH | 1 | $24.68 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.